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Abstract 
Background: Although central fat is a well‑known risk factor for cardiovascular disease (CVD) and cardiometabolic 
disorders, the effect of other regional fats or muscle distribution on CVD risk has not been fully investigated.
Methods: This was a cross‑sectional study using nationally representative samples of 15,686 subjects from the 2008–
2011 Korea National Health and Nutrition Examination Survey. Individual CVD risk was evaluated in adults aged ≥20 
without prior CVD, using atherosclerotic cardiovascular disease (ASCVD) risk equations according to the 2013 ACC/
AHA guidelines. Body composition was assessed by dual X‑ray absorptiometry.
Results: Ratio of leg fat to total fat (LF/TF ratio) was the most predictive for CVD among body fat or muscle distribu‑
tion parameters (AUC = 0.748, 95% CI 0.741–0.755). ASCVD risk score was gradually increased with decreased LF/
TF ratio (P < 0.001), and individuals whose LF/TF ratio in lowest tertile tended to belong to the high‑risk (10‑year risk 
>10%) group compared to those in the highest tertile (OR = 6.25, 95% CI 5.60–6.98). Subjects in the lowest tertile 
showed increased risk of cardiometabolic risk factor components including obesity, hypertension, diabetes, dyslipi‑
demia, chronic kidney disease, and albuminuria (OR range 2.57–11.24, all P < 0.001). In addition, a higher LF/TF ratio 
was associated with decreased ASCVD risk, even in subjects with multiple CVD risk factors. Multiple logistic regression 
analyses also demonstrated this association (OR = 1.85, 95% CI 1.36–2.52).
Conclusions: Among various body composition parameters, LF/TF ratio was superior in predicting higher CVD risk 
and a higher LF/TF ratio was independently associated with decreased risk of CVD and each cardiometabolic risk 
factor.
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Background
As obesity has become an increasingly epidemic disease, 
the incidence of cardiovascular and metabolic diseases 
have risen to become public health issues. Overweight 
and obesity are related to cardiovascular, and all-cause 
mortality [1]. More specifically, it has been demonstrated 
that excessive visceral fat is related to an increased risk 
of hypertension [2] and diabetes [3]. Although the asso-
ciation between excessive abdominal fat and risk of 
cardiovascular disease (CVD) and other cardiometa-
bolic diseases has been established, investigation of a 
relationship between other body fat accumulation and 
cardiometabolic disease is limited. In addition, the differ-
ent effect of regional body fat or muscle composition on 
CVD has not been fully understood.
Visceral adiposity is linked to altered myocardial glu-
cose uptake [4], concentric left ventricular remodeling 
[5], and left atrial dysfunction [6]. In contrast, subcuta-
neous fat depot was associated with higher cardiac out-
put and lower systemic vascular resistance [5]. Among 
subcutaneous fat, thigh girth or thigh fat is reported to 
attenuate risk for dyslipidemia [7] and glucose intoler-
ance [8]. The protective effect of larger hip circumference 
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to CVD has also been confirmed in previous studies of 
myocardial infarction [9], coronary heart disease (CHD) 
[10], and any CVD event [11]. Studies on lower-body fat 
have focused on the hip or thigh and indirectly assessed 
fat distribution by circumference. In addition, studies 
investigating on the effect of various body composition 
parameters on CVD risk are limited.
Dual-energy X-ray absorptiometry (DXA) has been 
recently used to assess body fat distribution as well as 
bone density. The regional fat measurement using DXA 
is reliable compared to computed tomography, a gold 
standard tool for measurement [12]. It also has the capa-
bility to scan whole body fat distribution with minimal 
radiation exposure.
We hypothesized that higher ratio of leg fat to total 
fat (LF/TF ratio) is related to low CVD risk regardless of 
other metabolic conditions. The aim of this study was to 
investigate the effect of each body fat or muscle distribu-
tion on CVD risk, and the association between LF/TF 
ratio and various CVD and cardiometabolic risk factor 
components in the general population.
Methods
Study population
This cross-sectional study utilized data collected from 
participants in the Korea National Health and Nutri-
tion Examination Surveys (KNHANES) 2008–2011. 
This nationwide, population-based, annual survey is 
conducted by the Korean government to monitor public 
health [13]. In KNHANES data, medical history includes 
smoking habits, alcohol consumption, exercise level, and 
disease diagnosis and/or treatment, based on direct inter-
views and self-reporting. Each KNHANES is comprised 
of independent data sets from the general population. As 
described in Fig.  1, among 37,753 participants, we ini-
tially selected those aged ≥20 without a prior history of 
CVD. We excluded those with missing data for DXA and 
CVD risk assessments, such that, 15,686 subjects (6761 
men and 8925 women) were included in the analysis. 
All participants provided written informed consent to 
participate in the original KNHANES. The survey pro-
tocol was approved by the institutional review board of 
the Korean Centers for Disease Control and Prevention 
(2008-04EXP-01-C, 2009-07CON-03-2C, 2010-02CON-
21-C, and 2011-02CON-06C).
Regional body distributions and cardiovascular disease 
risk
Fat mass and muscle mass were measured using DXA 
(QDR 4800A; Hologic Inc., Bedford, MA, USA). The 
DXA scans provided soft tissue and bone measurements 
for both arms and both legs, and the trunk. Values for 
these regions include total mass, fat mass, muscle mass. 
Leg measurement was assessed by sum of both legs 
including thigh and calf and arm measurement was indi-
cated as sum of both side upper arms and forearms val-
ues. CVD risk was evaluated using various approaches, 
including the 10-year atherosclerotic cardiovascular 
disease (ASCVD) risk score from the 2013 American 
College of Cardiology/American Heart Association 
(ACC/AHA) guidelines [14]. In addition, the Framing-
ham 10-year CVD risk score [15] and the Korean coro-
nary heart disease (CHD) prediction model [16] were 
assessed. Leg muscle mass and each CVD risk score 
was analyzed and categorized into sex-specific tertiles. 
Moreover, LF/TF ratio was divided into tertiles accord-
ing to obesity (body mass index [BMI] ≥25 kg/m2, Asian-
pacific criteria [17]) and sex. Individuals exhibiting ACC/
AHA ASCVD risk  >10%, Framingham CVD risk  >20%, 
and Korean CHD risk >5% were classified into the high-
risk group. We assessed regional body fat and muscle dis-
tributions’ receiver operator characteristic (ROC) curve 
to predict and high CVD risk. In addition, calculations 
of the area under the ROC curve (AUC) were compared 
among the fat and muscle parameters.
Cardiometabolic disease components
During surveys, blood pressure was manually measured 
using mercury sphygmomanometers (Baumanometer; 
W.A. Baum, Copiague, NY) three times in resting, seated 
positions, and final blood pressure values were assessed 
by averaging the second and third blood pressure 
Total n=37,753 assessed for eligibility
KNHANES IV-2 (2008, n=9,744)
KNHANES IV-3 (2009, n=10,533)
KNHANES V-1 (2010, n=8,958)
KNHANES V-2 (2011, n=8,518)
n=28,071, age ≥20 years 
Men (n=9,289)
Women (n=12,049)
Exclude those with age<20 years 
(n=9,682)
Final analysis set (n=15,686)
Men (n=6,761)
Women (n=8,925)
Exclude those with prior 
cardiovascular disease (n=1,211) 
Exclude those with insufficient 
information to calculate ACC/AHA 
ASCVD risk score (n=6,403),
no data of DXA(n=4,771) 
Fig. 1 The flow diagram of subject inclusion and exclusion in the 
Korean National Health and Nutrition Examination Surveys (KNHANES 
IV and V)
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readings. Overnight (≥8-h) fasting blood and spot urine 
samples were collected, refrigerated, and transported to 
a central laboratory (NeoDin Medical Institute, Seoul, 
South Korea) within 24 h. Diabetes was defined as using 
anti-diabetic agents, or who exhibited fasting plasma glu-
cose ≥126 mg/dL or glycated hemoglobin 6.5%. Individu-
als were considered to have hypertension if their systolic 
and/or diastolic blood pressure was ≥140/90 mmHg, or 
if they were taking anti-hypertensive medications. Cen-
tral obesity was defined as waist circumference ≥90 cm 
in men and  ≥85  cm in women [18]. Metabolic syn-
drome was based on the modified National Cholesterol 
Education Program Adult Treatment Panel III crite-
ria, adopted for the Korean population [19]. Hyper low 
density lipoprotein (LDL) cholesterolemia was charac-
terized as LDL  ≥160  mg/dL for both sexes, and hypo 
high density lipoprotein (HDL) cholesterolemia was 
defined as HDL <40 mg/dL for men, and <50 mg/dL for 
women. Hypertriglyceridemia was defined as serum tri-
glycerides  ≥150  mg/dL or taking triglyceride lowering 
agents. Estimated glomerular filtration rate (eGFR) was 
calculated using the Chronic Kidney Disease Epidemi-
ology collaboration equation [20], and chronic kidney 
disease was characterized as subjects with eGFR <60 mL/
min/1.73  m2 [21]. Albuminuria was characterized as 
having more than one positive dip-stick test or urine 
albumin-to-creatinine ratio  >30  mg/g [21]. Excluding 
individuals with missing urine data, 819 subjects were 
categorized into sex-specific LF/TF ratio tertiles and 
analyzed for risk of albuminuria. Regular exercise was 
defined as “engaging in intense physical activity, that 
made one very tired or breathe much harder than usual, 
and involved more than 20  min per session at least 3 
times per week” (e.g., running, jogging, mountain climb-
ing, fast cycling, fast swimming, playing soccer, playing 
basketball, playing squash or singles tennis, transporting 
heavy objects, etc.). An age cutoff point to classify adults 
as younger or older was 50 years, the median value.
Statistical analysis
Data are presented as the mean ± standard deviation for 
continuous variables, and as number, or percent for cat-
egorical variables. Simple correlation coefficients were 
used to assess correlations among regional fat depots. 
We analyzed participants’ characteristics according to 
LF/TF ratio tertiles, using one-way analysis of variance 
(ANOVA) to compare continuous variables and, χ2 tests 
for categorical variables, followed by post hoc analyses 
using the Bonferroni method. To evaluate the associa-
tion between LF/TF ratio and CVD risk, we attempted 
to minimize the effects of comorbidities. Subjects were 
classified according to the presence of hypertension, 
diabetes, metabolic syndrome, and obesity, and then χ2 
tests were applied to each group. Multivariable adjusted 
logistic regression analyses were used to test the inde-
pendent association between LF/TF ratio and high CVD 
risk (ACC/AHA ASCVD risk  >10%, Framingham CVD 
risk  >20% or Korean CHD risk  >5%) and between LF/
TF ratio and CVD risk factors. To measure the predic-
tion accuracy of each body compositions for high CVD 
risk, we calculated and compared AUC of each regional 
fat parameters. The comparison of the AUC for ROC 
curves was performed on the basis of the Delong test 
[22]. As total cholesterol, triglyceride, HDL cholesterol, 
LDL cholesterol, insulin, and the homeostasis model 
assessment of insulin resistance (HOMA-IR) values were 
not normally distributed, analyses were performed using 
log-transformed data in order to achieve approximately 
symmetrical distributions. Statistical analyses were per-
formed using IBM SPSS version 23.0 for Windows (IBM 
Corp., Armonk, NY, USA), and MedCalc (version 13.1; 
http://medcalc.software.informer.com/13.1); P < 0.05 was 
considered statistically significant.
Results
Baseline characteristics by ratio of leg fat to total fat
A total of 15,686 individuals with no history of CVD 
were analyzed in the present study (Fig.  1). Individuals 
with a higher LF/TF ratio tended to have smaller waist 
circumference, lower blood pressure, and more favorable 
metabolic conditions (glucose, insulin, HOMA-IR, LDL 
cholesterol, triglyceride, HDL cholesterol, and eGFR) 
(Table  1). Subsequently, a low prevalence of hyperten-
sion, diabetes, metabolic syndrome and chronic kidney 
disease was observed in the highest LF/TF ratio tertile 
in both non-obese and obese population. The correlation 
between leg fat and arm fat was strong (Pearson coeffi-
cient = 0.808, P < 0.001), while the association between 
leg fat and trunk fat was relatively weak (Pearson coeffi-
cient = 0.647, P < 0.001) in our population.
Various fat depots and cardiovascular disease risk
Leg fat was superior to arm, total, or trunk fat dis-
tributions in predicting higher values of ACC/AHA 
ASCVD risk scores (Fig.  2a). In addition, the LF/TF 
ratio (AUC  =  0.748, 95% CI 0.741–0.755) showed 
greater accuracy in predicting high ACC/AHA ASCVD 
risk compared to other fat distributions  (AUCarm fat/
total fat ratio  =  0.568, 95% CI 0.561–0.576,  AUCtrunk fat/
total fat ratio  =  0.717, 95% CI 0.709–0.724,  AUCwaist cir-
cumference =  0.659, 95% CI 0.652–0.667) (Fig.  2b). After 
stratifying into sex-specific leg fat and total fat ter-
tile separately, individuals with a higher leg fat even in 
higher total fat had shown lower ACC/AHA ASCVD 
risk compared to lower leg fat and lower total fat groups 
(Fig. 2c). LF/TF ratio tertiles were well-correlated with 
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Table 1 Baseline characteristics of study population by categories of ratio of leg fat to total fat (LF/TF ratio)
Data for continuous variables were expressed as mean ± standard deviation, and categorical variables were expressed as percent (%)
BMI body mass index; HDL cholesterol, high density lipoprotein cholesterol; LDL cholesterol, low density lipoprotein cholesterol; eGFR estimated glomerular filtration 
rate; WBC white blood cell; HOMA-IR homeostasis model assessment of insulin resistance
§ P < 0.05 by post hoc analyses when compared with lowest tertile
∥ P < 0.05 by post hoc analyses when compared with second tertile
a  Log-transformed
b  Regular exercise was defined as engaging in intense physical activity, that made one very tired or breathe much harder than usual, and involved more than 20 min 
per session at least 3 times per week
c  Chronic kidney disease was defined if subjects had an eGFR less than 60 ml/min/1.73 m2
Tertiles of LF/TF ratio
Lean Obese
Lowest tertile 
(n = 3592)
Second tertile 
(n = 3590)
Highest tertile 
(n = 3593)
Lowest tertile 
(n = 1631)
Second tertile 
(n = 1627)
Highest tertile 
(n = 1633)
Leg fat (kg) 4.3 ± 1.4 5.1 ± 1.7§ 5.4 ± 1.8§,∥ 5.1 ± 1.4 6.4 ± 1.7§ 7.6 ± 2.1§,∥
Total fat (kg) 15.9 ± 4.1 15.6 ± 4.4§ 13.9 ± 4.0§,∥ 21.5 ± 4.9 22.6 ± 5.3§ 23.0 ± 5.4§
LF/TF ratio (%) 26.4 ± 3.2 32.5 ± 3.3§ 38.7 ± 4.8§,∥ 23.8 ± 2.2 28.1 ± 1.8§ 33.0 ± 3.2§,∥
Age (year) 57.0 ± 13.5 47.5 ± 15.0§ 38.2 ± 14.2§,∥ 55.7 ± 12.3 51.1 ± 13.9§ 43.6 ± 14.6§,∥
Men (%) 40.4 40.3 40.3 49.2 49.2 49.2
Waist circumference 
(cm)
80.4 ± 6.5 76.7 ± 6.9§ 72.5 ± 7.1§,∥ 92.0 ± 6.8 91.0 ± 7.0§ 88.6 ± 7.3§,∥
BMI (kg/m2) 22.7 ± 1.7 22.0 ± 1.9§ 20.9 ± 2.1§,∥ 27.4 ± 2.1 27.5 ± 2.3 27.2 ± 2.2∥
Systolic blood pres‑
sure (mmHg)
122.1 ± 17.9 114.0 ± 16.6§ 107.8 ± 13.6§,∥ 125.9 ± 16.3 122.8 ± 16.4§ 117.4 ± 15.4§,∥
Diastolic blood pres‑
sure (mmHg)
76.2 ± 10.4 73.1 ± 10.2§ 70.1 ± 9.3§,∥ 79.9 ± 10.2 78.9 ± 10.4§ 76.5 ± 10.2§,∥
Fasting plasma 
glucose (mg/dL)
102.1 ± 26.6 93.6 ± 19.3§ 89.3 ± 12.2§,∥ 111.0 ± 31.8 101.6 ± 21.0§ 95.2 ± 15.9§,∥
Total cholesterol 
(mg/dL)a
194.4 ± 36.6 185.2 ± 33.2§ 172.9 ± 30.0§,∥ 200.3 ± 37.4 198.3 ± 36.5 191.3 ± 35.3§,∥
HDL cholesterol 
(mg/dL)a
50.7 ± 12.0 54.6 ± 13.0§ 57.5 ± 12.6§,∥ 47.3 ± 10.8 47.7 ± 11.1 49.8 ± 11.0§,∥
Triglycerides (mg/
dL)a
154.4 ± 114.1 115.6 ± 87.4§ 85.1 ± 67.8§,∥ 190.6 ± 150.1 174.0 ± 121.3§ 136.3 ± 98.3§,∥
LDL cholesterol 
(mg/dL)a
118.4 ± 33.5 112.5 ± 29.5§ 102.8 ± 26.6§,∥ 122.1 ± 34.0 122.0 ± 32.5 119.6 ± 31.3
eGFR (mL/
min/1.73 m2)
90.1 ± 16.1 97.3 ± 16.5§ 103.6 ± 16.1§,∥ 98.1 ± 16.8 92.2 ± 16.2§ 97.9 ± 16.6§,∥
WBC  (103/μL) 6.1 ± 1.7 5.8 ± 1.6§ 5.6 ± 1.5§,∥ 6.6 ± 1.8 6.5 ± 1.7 6.2 ± 1.6§,∥
Insulin (ųU/mL)a 9.4 ± 5.4 8.7 ± 3.9§ 8.4 ± 3.4§,∥ 13.0 ± 7.6 12.1 ± 5.8 11.1 ± 4.6
HOMA‑IRa 2.4 ± 2.3 2.0 ± 1.1§ 1.9 ± 0.8§,∥ 3.7 ± 3.4 3.1 ± 1.9§ 2.6 ± 1.2§,∥
Alcohol (g/week) 73.8 ± 122.5 63.5 ± 113.3§ 44.6 ± 84.2§,∥ 82.0 ± 132.0 78.9 ± 123.5 67.8 ± 113.4§
Current smoker (%) 20.5 21.6 20.9 21.3 23.3 24.2
Regular exercise 
(%)b
24.2 24.7 22.0§ 26.4 27.2 28.5
Hypertension (%) 37.5 17.9§ 7.0§,∥ 53.8 40.7§ 24.0§,∥
Diabetes (%) 15.2 4.1§ 1.1§,∥ 26.4 12.2§ 4.3§,∥
Metabolic syndrome 
(%)
37.6 11.9§ 2.4§,∥ 72.4 60.2§ 35.0§,∥
Chronic kidney 
disease (%)c
4.3 2.1§ 0.6§,∥ 5.3 3.7 2.2§
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ACC/AHA ASCVD score tertiles (Fig.  2d). The other 
risk scores showed similar results (Additional file 1: Fig-
ure S1).
Ratio of leg fat to total fat and cardiometabolic disease risk 
components
We have demonstrated a relationship between LF/TF 
ratio and CVD risk; likewise, we analyzed the risks of 
each cardiometabolic factor component as related to 
LF/TF ratio. In Table 2, individuals with the lowest LF/
TF ratio tertile had the highest risk of obesity, hyper-
tension, diabetes, dyslipidemia, metabolic syndrome, 
and kidney dysfunction (OR range 2.64–11.24, all 
P  <  0.001). To assess the association between LF/TF 
ratio and CVD risk independent of other covariates, we 
performed multiple logistic regression analysis. After 
sequential adjustment for confounding covariates such 
as age, sex, obesity, smoking, alcohol, systolic blood 
pressure, serum glucose, dyslipidemia, BMI, menopause 
state and kidney function, individuals with lower LF/TF 
ratios were found to have significantly higher adjusted 
odds ratios (AORs) for high ACC/AHA ASCVD risk 
(AOR = 1.85, 95% CI 1.36–2.52, P < 0.001) compared to 
subjects with the highest LF/TF ratio. The AOR for high 
a
c
b
d
Fig. 2 Regional body fat distributions, receiver operating characteristic (ROC) curves, and high ACC/AHA ASCVD risk. a ROC curves to predict high 
ACC/AHA ASCVD risk (>10%) for each regional fat. b ROC curves to predict high ACC/AHA ASCVD risk for other regional fat ratios and waist circum‑
ference. c Proportion of individuals with high ACC/AHA ASCVD risk by leg fat and total fat tertiles. d Proportion of individuals with ACC/AHA ASCVD 
risk score tertiles by LF/TF ratio. **P < 0.001
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risk of CVD gradually increased in lower LF/TF ratio, in 
other models.
Ratio of leg fat to total fat is associated with cardiovascular 
disease risks independent of hypertension, diabetes, 
and metabolic syndrome
The increasing average ACC/AHA ASCVD risk scores 
was linked with decreased LF/TF ratio in both non-obese 
and obese group, and this finding was shown in both 
young and old age group (Additional file  2: Figure S2). 
The distribution of high-risk subjects according to LF/
TF ratio tertiles showed the same trend as ACC/AHA 
ASCVD risk scores regardless of age group (9.1, 20.1, and 
38.4% for highest, second, and lowest tertiles, respec-
tively, P < 0.001).
Subgroup analyses were conducted to identify the LF/
TF ratio and CVD risk independent of other metabolic 
conditions. Figure 3 depicts that, regardless of the pres-
ence of hypertension, diabetes, metabolic syndrome or 
insulin resistance state, a higher LF/TF ratio was asso-
ciated with lower ACC/AHA ASCVD risks in both 
non-obese and obese group. When other CVD risk 
assessments were applied, similar results were observed 
(Additional file 3: Figure S3, Additional file 4: Figure S4). 
Furthermore, people with a higher LF/TF ratio were less 
likely to have multiple CVD risk factors. In individuals 
with a higher LF/TF ratio having multiple risk factors, 
their CVD risk was not as high as those with lower LF/
TF ratios, regardless of CVD risk models (Fig.  3e). We 
further assessed ACC/AHA ASCVD risk in leg mus-
cle mass in relation to LF/TF ratio. Along with a higher 
LF/TF ratio, higher leg muscle mass was associated with 
lower ACC/AHA ASCVD risk and both LF/TF ratio and 
leg muscle mass synergistically decreased ACC/AHA 
ASCVD risk (Fig. 3f ).
Discussion
This large, nationally representative, population-based 
study demonstrated that LF/TF ratio was superior to 
other parameters in predicting high CVD risk, and 
that people with a higher LF/TF ratio tended to have 
decreased risk of CVD and other cardiometabolic risk 
components. LF/TF ratio was associated with CVD 
risk independent of hypertension, diabetes, obesity, and 
metabolic syndrome, and more risk attenuation was 
observed in healthy conditions. In addition, subjects with 
a higher LF/TF ratio and multiple CVD risk factors had a 
CVD risk comparable to those with a lower LF/TF ratio 
and few CVD risk factors. The association between LF/
TF ratio and CVD risk remained significant after adjust-
ing for other confounding factors.
Regional fat accumulation, rather than BMI, has 
a strong correlation with cardiometabolic disease 
Table 2 Odds ratio and 95% confidential interval of cardi-
ometabolic disease risk factors and high CVD risk accord-
ing to sex-specific LF/TF ratio tertiles in adults
Risk factors are adjusted for age, sex, exercise, smoking, and alcohol drinking
Model 1: adjusted for age, and sex
Model 2: adjusted for age, sex, exercise, smoking, alcohol drink, and BMI
Model 3: adjusted for age, sex, exercise, smoking, alcohol drink, BMI, systolic 
blood pressure, fasting blood glucose, hyper LDL-cholesterolemia, eGFR, and 
menopause
a  Obesity was defined BMI ≥25 kg/m2
b  Central obesity was defined waist circumference ≥90 cm in men, ≥85 cm in 
women
c  Hyper LDL-cholesterolemia was characterized as calculated LDL 
cholesterol ≥160 mg/dL
d  Hypo HDL-cholesterolemia was defined as serum HDL cholesterol <40 mg/dL 
for men, and <50 mg/dL for women
e  Hypertriglyceridemia was defined as serum triglycerides ≥150 mg/dL or 
taking triglyceride lowering agents
f  Chronic kidney disease was defined if subjects had an eGFR less than 60 mL/
min/1.73 m2
g  Albuminuria was characterized urine albumin-creatinine ratio >30 mg/g or 
urine protein ≥2 positive. The LF/TF ratio tertile was newly categorized in 819 
subjects with urine test results
LF/TF ratio
Highest tertile Second tertile Lowest tertile
Risk factor
 Obesitya 1 (referent) 3.72 (3.33–4.15) 7.67 (6.81–8.23)
 Central  obesityb 1 (referent) 4.29 (3.83–4.82) 9.22 (8.16–10.42)
 Hypertension 1 (referent) 2.05 (1.80–2.34) 3.57 (3.14–4.07)
 Diabetes 1 (referent) 2.88 (2.19–3.78) 8.89 (6.87–11.50)
 Hyper LDL‑cho‑
lesterolemiac
1 (referent) 2.14 (1.76–2.60) 2.72 (2.23–3.32)
 Hypo HDL‑cho‑
lesterolemiad
1 (referent) 1.92 (1.76–2.11) 2.91 (2.64–3.22)
 Hypertriglyceri‑
demiae
1 (referent) 3.01 (2.69–3.37) 6.14 (5.46–6.90)
 Metabolic 
syndrome
1 (referent) 4.06 (3.53–4.67) 11.24 (9.78–12.93)
 Chronic kidney 
 diseasef
1 (referent) 1.97 (1.30–2.99) 2.57 (1.73–3.81)
 Albuminuriag 1 (referent) 2.03 (1.21–3.41) 2.64 (1.57–4.44)
High ACC/AHA ASCVD risk
 Crude 1 (referent) 2.53 (2.25–2.84) 6.25 (5.60–6.98)
 Model 1 1 (referent) 1.95 (1.56–2.44) 3.69 (2.98–4.57)
 Model 2 1 (referent) 1.65 (1.30–2.08) 2.91 (2.31–3.66)
 Model 3 1 (referent) 1.26 (0.92–1.71) 1.85 (1.36–2.52)
High Framingham CVD risk
 Crude 1 (referent) 2.48 (2.16–2.84) 6.32 (5.56–7.18)
 Model 1 1 (referent) 1.96 (1.61–2.39) 4.09 (3.39–4.94)
 Model 2 1 (referent) 1.70 (1.38–2.09) 3.21 (2.63–3.92)
 Model 3 1 (referent) 1.43 (1.07–1.91) 2.37 (1.79–3.15)
High Korean CHD risk
 Crude 1 (referent) 3.43 (2.30–5.13) 7.98 (5.48–11.63)
 Model 1 1 (referent) 2.47 (1.59–3.82) 4.08 (2.69–6.17)
 Model 2 1 (referent) 2.39 (1.52–3.75) 3.64 (2.37–5.60)
 Model 3 1 (referent) 1.94 (1.11–3.38) 2.57 (1.52–4.37)
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incidence [10]. The role of each body fat depot to meta-
bolic health seems to vary. Abdominal fat accumulation 
with visceral fat is adversely correlated with cardiometa-
bolic disease [3, 23–25], accounted for disparate pheno-
type of subcutaneous and visceral adipocyte [26]. High 
visceral fat with low subcutaneous fat could be a marker 
for fat accumulation in vessel and liver, accelerating ath-
erosclerosis and fatty liver [27, 28]. Furthermore, the role 
of subcutaneous fat seems to be diverse according to the 
body compartment. Deep subcutaneous adipose tissue 
a b
c d
e f
Fig. 3 Difference in ACC/AHA ASCVD risk according to LF/TF ratio tertiles, subgroup analysis. Proportion of individuals with high ACC/AHA ASCVD 
risk (>10%) stratified by a hypertension, b diabetes, c metabolic syndrome, d insulin resistance (HOMA‑IR), and e central obesity. f Number of 
cardiovascular risk factors according to LF/TF tertiles. Risk factors are obesity, hypertension, diabetes, hyper LDL‑cholesterolemia, and hypertriglyc‑
eridemia. HTN hypertension, DM diabetes mellitus, MetS metabolic syndrome, HOMA-IR homeostasis model assessment of insulin resistance
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was demonstrated to have similar phenotype of visceral 
fat, with increased insulin resistance and high CVD risk 
score, whereas superficial subcutaneous adipose tissue 
was the opposite [29]. Subcutaneous fat in the lower-
body region has more potent properties of metabolism 
[30–32]. In healthy postmenopausal women, leg fat 
mass was a significant independent predictor of insulin 
sensitivity, reducing risk for hyperinsulinemia and insu-
lin resistance, whereas trunk fat was associated with 
increased risk of those conditions [30]. In addition, this 
association was consistently maintained independent of 
body weight [31]. The results of our study support those 
of previous studies regarding the importance of body fat 
distribution as a predisposing risk factor for CVD and 
the extent to which LF/TF ratio is a better predictor com-
pared to upper-body fat (ratio of arm fat to total fat) or 
trunk fat. Furthermore, we found that a high LF/TF ratio 
had stronger association with lower CVD risk when com-
bined with sufficient leg muscle mass.
Previous studies using DXA provided limited results on 
the effect of regional adiposity distributions on CVD risk 
and were mainly confined to postmenopausal women. A 
study of postmenopausal women showed the association 
between regional fat and indirect CVD risk using hyper-
insulinemia, and dyslipidemia [31]. Since then, a Danish 
group reports that peripheral fat mass correlated with 
aortic calcification in elderly females [33]. Both reports 
emphasized that localization of fat mass was more 
important than total body weight to atherosclerosis. The 
correlation between regional fat distribution on cardio-
metabolic risk factors, including blood pressure, HOMA-
IR, high-sensitivity C-reactive protein, and dyslipidemia 
has been recently reported in a European study [30]. 
However, it too was limited to postmenopausal women 
and lacked of a comprehensive CVD risk assessment. To 
our knowledge, the present study is the first investigate 
on the impact of leg fat distribution on comprehensive 
CVD risk in a large general Korean population.
Although the biologic mechanism of each body fat 
depot has not been fully investigated, the different 
regional fat deposit seems to have different functional 
properties. Subcutaneous fat in the gluteofemoral region 
is considered a ‘metabolic sink’ due to its low rate of 
lipolysis, fatty acid uptake and blood flow [34]. In terms 
of adipose tissue lipolysis, the leg fat is the most sensi-
tive adipose tissue to insulin [35]. These distinct fea-
tures of lower-body fat prevent chronic exposure to 
high lipid concentration. In addition, adiponectin level 
and insulin sensitivity correlates with leg fat mass [32, 
36]. Another study demonstrated the profound secre-
tion of lipokine, palmitoleate from leg fat using venoar-
terial difference sampling [37]. A lower LF/TF ratio was 
associated with increased risk of each cardiometabolic 
risk factor component in our results. It was more closely 
related to the risk of obesity and diabetes than to hyper-
tension and dyslipidemia, with the highest OR associ-
ated with metabolic syndrome, suggesting that a lower 
LF/TF ratio combined with another cardiometabolic 
risk factor component might synergistically increase its 
harmful effect. Furthermore, a lower LF/TF ratio was 
related to chronic kidney disease and even albuminuria 
risk in our results. Considering albuminuria as a marker 
of a premature stage of inflammation and CVD progres-
sion [38], a lower-body fat depot might be involved the 
in early development of CVD. As an interesting finding, 
individuals with multiple risk components and a higher 
LF/TF ratio had a CVD risk equivalent to those with a 
lower LF/TF ratio and few risk factors. The current study 
not only complemented the previous studies by show-
ing a negative association of LF/TF ratio with CVD risk, 
but also revealed that higher LF/TF ratio is related with 
attenuated CVD risk even in high risk group. Moreover, 
the proportion at high risk was the highest in non-obese 
individuals in the lowest LF/TF ratio tertile, highlighting 
the importance of the LF/TF ratio in non-obese patients. 
These findings support previous studies suggesting the 
importance of the fat distribution effect to risk of CVD in 
people with normal BMI [39], and implying that regional 
fat can distinguish high CVD risk patients in a non-obese 
group [40, 41]. In non-obese group with diabetes, the 
correlation was not significant in our result might suggest 
the overwhelmed impact of diabetes on CVD.
To converse or attenuate the inappropriate impact of 
visceral fat, exercise should be recommended. 12-week 
standard aerobic exercise program effectively reduced 
visceral adipose tissue, and change in visceral fat area, but 
not subcutaneous fat was significantly associated with 
insulin resistance [42]. 1-year exercise and lifestyle modi-
fication program decreased visceral fat, but not subcuta-
neous fat, which resulted in enhancing adiponectin levels 
[43]. This impact of exercise was not limited in adult, but 
also was shown in obese adolescent individuals [44]. In 
addition, a multidisciplinary clinical trial including CT-
scan, metabolomics, and transcriptomics suggested that 
promoting subcutaneous fat expansion could be a thera-
peutic option for reducing metabolic complications in 
obese individuals impending diabetes or cardiovascular 
diseases [45]. Restoring dysregulated inflammatory and 
oxidative phosphorylation pathways in the adipose tissue 
would be a promising target for the treatment of athero-
sclerosis and insulin resistance [46].
This study has some limitations. First, due to its cross-
sectional design, we could not assert direct causal-
ity between LF/TF ratio and CVD risk. In addition, we 
applied indirect parameters to assess CVD risk. How-
ever, we used multiple surrogate CVD risk models with 
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detailed statistical analyses to overcome this issue. Sec-
ond, KHNASE did not collect each individual’s medica-
tion information, and the potential medication effect on 
CVD risk was not analyzed. Third, DXA could not exactly 
distinguish between subcutaneous fat and intramuscular 
fat.
Despite these limitations, our study has several 
strengths. First, it utilized data from a large, national, 
population-based study, guaranteeing statistical reli-
ability without selection bias. We were able to divide 
sex-specific LF/TF ratio tertiles, whereas previous stud-
ies on lower-body fat were conducted mostly in women. 
Second, various equations and adjustment models were 
applied and they consistently showed similar results. 
Third, we limited the study population by excluding those 
with prior CVD history, to prevent reverse causality. The 
novelty of our results was that LT/TF ratio was superior 
to other regional fat depots as a predictive marker of high 
CVD risk. Furthermore, CVD risk lowering impact of 
LF/TF ratio was more prominent among individuals with 
high CVD risks.
The LF/TF ratio may distinguish individuals with a high 
CVD risk and provide reinforced risk modification to 
those subjects. In addition, our finding that a higher LF/
TF ratio might have a beneficial effect on CVD risk, could 
be a clue for “obesity paradox” which refers the decreased 
risk of death in overweight individuals compared to those 
in normal weight. Although we only analyzed adult pop-
ulation in this study using DXA, technical assessment of 
body composition [47], and association between regional 
fat depots and cardiometabolic risk in obese adoles-
cents needs to be further investigated. Prospective, well-
designed, longitudinal studies with sufficient laboratory 
and cardiovascular imaging resources are warranted to 
identify the complex relationship between LF/TF ratio 
and CVD risk.
Conclusions
This nationwide survey of a representative sample of 
Korean population demonstrated that LF/TF ratio was 
important for predicting higher CVD risk and, was asso-
ciated with increased risks of CVD, independent for 
other cardiovascular factors.
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